The new bedside monitoring system continuously measures heart rate, breath rate and motion without requiring patient contact, according to the release. Constantly monitoring vitals and receiving reports of vital trends can help reduce the potential for an adverse event, according to the release.
More Articles on the FDA:
FDA Clears Smiths Medical to Market Patient-Controlled Pain
FDA Approves Gore Medical’s Viabhan Endoprosthesis Devices Use Expansion
FDA, European Medicines Agency to Collaborate on Generic Drug Approvals
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
